As of 2026-05-21, the Relative Valuation of Samrat Pharmachem Ltd (530125.BO) is 159.99 INR. This relative valuation is based on P/E multiples. With the latest stock price at 208.55 INR, the upside of Samrat Pharmachem Ltd based on Relative Valuation is -23.3%.
The range of the Relative Valuation is (125.43) - 475.09 INR.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 29.3x | 27.4x |
| Forward P/E multiples | 17.1x - 20.2x | 19.9x |
| Fair Price | (125.43) - 475.09 | 159.99 |
| Upside | -160.1% - 127.8% | -23.3% |
| Date | P/E |
| 2026-05-20 | -38.48 |
| 2026-05-19 | -39.47 |
| 2026-05-18 | -39.64 |
| 2026-05-15 | -39.47 |
| 2026-05-14 | -38.48 |
| 2026-05-13 | -39.44 |
| 2026-05-12 | -40.02 |
| 2026-05-11 | -40.02 |
| 2026-05-08 | -39.67 |
| 2026-05-07 | -40.96 |
| 2026-05-06 | -38.03 |
| 2026-05-05 | -39.24 |
| 2026-05-04 | -39.36 |
| 2026-04-30 | -38.87 |
| 2026-04-29 | -38.77 |
| 2026-04-28 | -39.02 |
| 2026-04-27 | -38.65 |
| 2026-04-24 | -39.48 |
| 2026-04-23 | -40.72 |
| 2026-04-22 | -40.96 |
| 2026-04-21 | -40.59 |
| 2026-04-20 | -40.30 |
| 2026-04-17 | -41.46 |
| 2026-04-16 | -40.58 |
| 2026-04-15 | -39.61 |
| 2026-04-13 | -38.74 |
| 2026-04-10 | -38.21 |
| 2026-04-09 | -38.91 |
| 2026-04-08 | -40.10 |
| 2026-04-07 | -38.56 |
| 2026-04-06 | -38.94 |
| 2026-04-02 | -38.09 |
| 2026-04-01 | -35.83 |
| 2026-03-30 | -35.53 |
| 2026-03-27 | -35.99 |
| 2026-03-25 | -37.46 |
| 2026-03-24 | -36.90 |
| 2026-03-23 | -38.19 |
| 2026-03-20 | -39.37 |
| 2026-03-19 | -38.56 |
| 2026-03-18 | -39.78 |
| 2026-03-17 | -37.17 |
| 2026-03-16 | -38.02 |
| 2026-03-13 | -39.17 |
| 2026-03-12 | -38.73 |
| 2026-03-11 | -42.04 |
| 2026-03-10 | -40.57 |
| 2026-03-09 | -37.26 |
| 2026-03-06 | -37.45 |
| 2026-03-05 | -38.48 |